Detalhe da pesquisa
1.
6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial.
Lancet
; 393(10191): 2591-2598, 2019 06 29.
Artigo
Inglês
| MEDLINE | ID: mdl-31178155
2.
Sarcomas in patients over 90: Natural history and treatment-A nationwide study over 6 years.
Int J Cancer
; 145(8): 2135-2143, 2019 10 15.
Artigo
Inglês
| MEDLINE | ID: mdl-30924137
3.
Adjuvant ovarian suppression in premenopausal breast cancer.
N Engl J Med
; 372(5): 436-46, 2015 Jan 29.
Artigo
Inglês
| MEDLINE | ID: mdl-25495490
4.
Assessment of the prognostic role of a 94-single nucleotide polymorphisms risk score in early breast cancer in the SIGNAL/PHARE prospective cohort: no correlation with clinico-pathological characteristics and outcomes.
Breast Cancer Res
; 19(1): 98, 2017 Aug 22.
Artigo
Inglês
| MEDLINE | ID: mdl-28830573
5.
Genetic predisposition to in situ and invasive lobular carcinoma of the breast.
PLoS Genet
; 10(4): e1004285, 2014 04.
Artigo
Inglês
| MEDLINE | ID: mdl-24743323
6.
Bevacizumab plus neoadjuvant chemotherapy in patients with HER2-negative inflammatory breast cancer (BEVERLY-1): a multicentre, single-arm, phase 2 study.
Lancet Oncol
; 17(5): 600-11, 2016 05.
Artigo
Inglês
| MEDLINE | ID: mdl-27032301
7.
Randomized phase 2 neoadjuvant trial evaluating anastrozole and fulvestrant efficacy for postmenopausal, estrogen receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients: Results of the UNICANCER CARMINA 02 French trial (UCBG 0609).
Cancer
; 122(19): 3032-40, 2016 Oct.
Artigo
Inglês
| MEDLINE | ID: mdl-27315583
8.
Weight and weight changes throughout life and postmenopausal breast cancer risk: a case-control study in France.
BMC Cancer
; 16(1): 761, 2016 Sep 29.
Artigo
Inglês
| MEDLINE | ID: mdl-27681230
9.
Prognostic significance of an early decline in serum alpha-fetoprotein during chemotherapy for ovarian yolk sac tumors.
Gynecol Oncol
; 142(3): 452-7, 2016 09.
Artigo
Inglês
| MEDLINE | ID: mdl-27401840
10.
Personalised chemotherapy based on tumour marker decline in poor prognosis germ-cell tumours (GETUG 13): a phase 3, multicentre, randomised trial.
Lancet Oncol
; 15(13): 1442-1450, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25456363
11.
Use of [(18)F]-FDG PET to predict response to neoadjuvant trastuzumab and docetaxel in patients with HER2-positive breast cancer, and addition of bevacizumab to neoadjuvant trastuzumab and docetaxel in [(18)F]-FDG PET-predicted non-responders (AVATAXHER): an open-label, randomised phase 2 trial.
Lancet Oncol
; 15(13): 1493-1502, 2014 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-25456368
12.
6 months versus 12 months of adjuvant trastuzumab for patients with HER2-positive early breast cancer (PHARE): a randomised phase 3 trial.
Lancet Oncol
; 14(8): 741-8, 2013 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-23764181
13.
Prognostic stratification ability of the CPS+EG scoring system in HER2-low and HER2-zero early breast cancer treated with neoadjuvant chemotherapy.
Eur J Cancer
; 202: 114037, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38554542
14.
Night work and breast cancer: a population-based case-control study in France (the CECILE study).
Int J Cancer
; 132(4): 924-31, 2013 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-22689255
15.
Correlation of HER2, FCGR2A, and FCGR3A gene polymorphisms with trastuzumab related cardiac toxicity and efficacy in a subgroup of patients from UNICANCER-PACS 04 trial.
Breast Cancer Res Treat
; 139(3): 789-800, 2013 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-23780683
16.
Protein expression, survival and docetaxel benefit in node-positive breast cancer treated with adjuvant chemotherapy in the FNCLCC-PACS 01 randomized trial.
Breast Cancer Res
; 13(6): R109, 2011.
Artigo
Inglês
| MEDLINE | ID: mdl-22044691
17.
Determinants of serum concentrations of 1,1-dichloro-2,2-bis(p-chlorophenyl)ethylene and polychlorinated biphenyls among French women in the CECILE study.
Environ Res
; 111(6): 861-70, 2011 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-21684540
18.
Breast cancer risk by occupation and industry: analysis of the CECILE study, a population-based case-control study in France.
Am J Ind Med
; 54(7): 499-509, 2011 Jul.
Artigo
Inglês
| MEDLINE | ID: mdl-21472744
19.
[Breast carcinoma metastasis into a renal cell carcinoma]. / Métastase d'un carcinome mammaire dans un carcinome rénal.
Ann Pathol
; 31(5): 399-401, 2011 Oct.
Artigo
Francês
| MEDLINE | ID: mdl-21982250
20.
Efficacy of trastuzumab in routine clinical practice and after progression for metastatic breast cancer patients: the observational Hermine study.
Oncologist
; 15(8): 799-809, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-20671105